Riken Vitamin Statistics

Total Valuation

Riken Vitamin has a market cap or net worth of JPY 77.10 billion. The enterprise value is 69.10 billion.

Market Cap	77.10B
Enterprise Value	69.10B

Important Dates

The next estimated earnings date is Wednesday, May 14, 2025.

Earnings Date	May 14, 2025
Ex-Dividend Date	Mar 28, 2025

Share Statistics

Riken Vitamin has 29.87 million shares outstanding. The number of shares has decreased by -6.24% in one year.

Current Share Class	n/a
Shares Outstanding	29.87M
Shares Change (YoY)	-6.24%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	11.06%
Owned by Institutions (%)	26.95%
Float	20.03M

Valuation Ratios

The trailing PE ratio is 9.33.

PE Ratio	9.33
Forward PE	n/a
PS Ratio	0.81
PB Ratio	0.96
P/TBV Ratio	0.97
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	8.12
EV / Sales	0.73
EV / EBITDA	n/a
EV / EBIT	7.46
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.05, with a Debt / Equity ratio of 0.13.

Current Ratio	3.05
Quick Ratio	2.08
Debt / Equity	0.13
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	77.14

Financial Efficiency

Return on equity (ROE) is 10.70% and return on invested capital (ROIC) is 6.34%.

Return on Equity (ROE)	10.70%
Return on Assets (ROA)	4.99%
Return on Invested Capital (ROIC)	6.34%
Return on Capital Employed (ROCE)	9.70%
Revenue Per Employee	51.31M
Profits Per Employee	4.58M
Employee Count	1,857
Asset Turnover	0.82
Inventory Turnover	3.40

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -4.94% in the last 52 weeks. The beta is -0.10, so Riken Vitamin's price volatility has been lower than the market average.

Beta (5Y)	-0.10
52-Week Price Change	-4.94%
50-Day Moving Average	2,425.06
200-Day Moving Average	2,525.73
Relative Strength Index (RSI)	64.84
Average Volume (20 Days)	64,065

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Riken Vitamin had revenue of JPY 95.28 billion and earned 8.51 billion in profits. Earnings per share was 276.53.

Revenue	95.28B
Gross Profit	31.53B
Operating Income	9.26B
Pretax Income	11.52B
Net Income	8.51B
EBITDA	n/a
EBIT	9.26B
Earnings Per Share (EPS)	276.53

Full Income Statement

Balance Sheet

The company has 18.67 billion in cash and 10.63 billion in debt, giving a net cash position of 8.03 billion or 268.88 per share.

Cash & Cash Equivalents	18.67B
Total Debt	10.63B
Net Cash	8.03B
Net Cash Per Share	268.88
Equity (Book Value)	80.12B
Book Value Per Share	2,637.79
Working Capital	43.61B

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 33.09%, with operating and profit margins of 9.72% and 8.93%.

Gross Margin	33.09%
Operating Margin	9.72%
Pretax Margin	12.09%
Profit Margin	8.93%
EBITDA Margin	n/a
EBIT Margin	9.72%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 88.00, which amounts to a dividend yield of 3.41%.

Dividend Per Share	88.00
Dividend Yield	3.41%
Dividend Growth (YoY)	8.64%
Years of Dividend Growth	3
Payout Ratio	n/a
Buyback Yield	6.24%
Shareholder Yield	9.65%
Earnings Yield	11.04%
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on March 30, 2020. It was a forward split with a ratio of 2.

Last Split Date	Mar 30, 2020
Split Type	Forward
Split Ratio	2

Scores

Riken Vitamin has an Altman Z-Score of 3.65.

Altman Z-Score	3.65
Piotroski F-Score	n/a